Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Åke Lernmark

Principal investigator

Default user image.

Protection from bb rat diabetes by the platelet-activating factor inhibitor BN50730

Author

  • Lance W. Jobe
  • Roel Ubungen
  • Charles J. Goodner
  • Denis G. Baskin
  • Pierre Braquet
  • Åke Lernmark

Summary, in English

The platelet-activating factor inhibitor BN50730, a hetrazepine, was injected intraperitoneally daily from 30 days of age into diabetes-prone BB rats. While 96% (22123) Tween 80 injected control rats developed diabetes, 0.05 mg/kg BN50730 decreased the frequency to 72% (17/24;n.s.) and 0.5 mg/kg to 56% (14125;p <0.01). Mean onset age in controls was 81 ± 9 days (mean ± SD), but BN50730 delayed onset to 87 ± 15 days in the low and 93 ± 12.days (p <0.01) in high dose rats. The relative degree of insulitis was reduced in both low (p <0.01) and high (p <0.05) dose treated groups. Serum insulin in young prediabetic controls decreased from 84±34 μU/ml to 38 ± 20 in the 22 rats developing diabetes (p <0.001). Serum insulin in BN50730-protected compared to unprotected rats was 114±49 and 32±22 (p <0.001) in the low, and 91 ± 4 6 and 21 ± 15 (p <0.001) μU/ml in the high dose group, respectively. Increased serum insulin correlated with preserved islet β cells and decreased insulitis. Treatment did not affect thyroiditis. Thus, platelet-activating factor may be involved in insulitis pathogenesis and platelet-activating factor inhibitors may decrease autoimmune β cell destruction.

Publishing year

1993-01-01

Language

English

Pages

259-266

Publication/Series

Autoimmunity

Volume

16

Issue

4

Document type

Journal article

Publisher

Taylor & Francis

Keywords

  • Biobreeding (BB) rats
  • IDDM (insulin-dependent diabetes mellitus)
  • Insulitis
  • PAF

Status

Published

ISBN/ISSN/Other

  • ISSN: 0891-6934